Found 9 results
[ Author(Desc)] Keyword Title Type Year
Filters: Keyword is Cholesterol  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Lebold KM, Kirkwood JS, Taylor AW, Choi J, Barton CL, Miller GW, La Du J, Jump DB, Stevens JFrederik, Tanguay RL et al..  2013.  Novel liquid chromatography-mass spectrometry method shows that vitamin E deficiency depletes arachidonic and docosahexaenoic acids in zebrafish (Danio rerio) embryos.. Redox Biol. 2:105-13.
N
Nakamura Y, Kulkarni NN, Takahashi T, Alimohamadi H, Dokoshi T, Liu E, Shia M, Numata T, Luo EWc, Gombart AF et al..  2024.  Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis.. J Clin Invest. 134(5)
R
Roomi MW.  1997.  Association between hyperlipidemia and hepatic cytochrome P-450 in guinea pigs.. Res Commun Mol Pathol Pharmacol. 97(2):139-50.
T
Traber MG.  2007.  Heart disease and single-vitamin supplementation.. Am J Clin Nutr. 85(1):293S-299S.
Traber MG, Leonard SW, Bobe G, Fu X, Saltzman E, Grusak MA, Booth SL.  2015.  α-Tocopherol disappearance rates from plasma depend on lipid concentrations: studies using deuterium-labeled collard greens in younger and older adults.. Am J Clin Nutr. 101(4):752-9.
Traber MG, Jialal I.  2000.  Measurement of lipid-soluble vitamins--further adjustment needed? Lancet. 355(9220):2013-4.
Tripathy S, Torres-Gonzalez M, Jump DB.  2010.  Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.. J Lipid Res. 51(9):2642-54.
Z
Zhang W-J, Bird KE, McMillen TS, Leboeuf RC, Hagen TM, Frei B.  2008.  Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.. Circulation. 117(3):421-8.
Zhang W-J, Wei H, Frei B.  2010.  The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice.. Exp Biol Med (Maywood). 235(5):633-41.